These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28566863)

  • 21. Clinical and Radiographic Evaluation of the Effectiveness of Formocresol, Mineral Trioxide Aggregate, Portland Cement, and Enamel Matrix Derivative in Primary Teeth Pulpotomies: A Two Year Follow-Up.
    Yildirim C; Basak F; Akgun OM; Polat GG; Altun C
    J Clin Pediatr Dent; 2016; 40(1):14-20. PubMed ID: 26696101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Success of mineral trioxide aggregate in pulpotomized primary molars.
    Farsi N; Alamoudi N; Balto K; Mushayt A
    J Clin Pediatr Dent; 2005; 29(4):307-11. PubMed ID: 16161395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and radiographic success of mineral trioxide aggregate compared with formocresol as a pulpotomy treatment in primary molars: a systematic review and meta-analysis.
    Marghalani AA; Omar S; Chen JW
    J Am Dent Assoc; 2014 Jul; 145(7):714-21. PubMed ID: 24982277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of formocresol, calcium hydroxide, ferric sulfate, and MTA primary molar pulpotomies.
    Yildiz E; Tosun G
    Eur J Dent; 2014 Apr; 8(2):234-240. PubMed ID: 24966776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
    Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
    Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mineral trioxide aggregate as pulp capping agent for primary teeth pulpotomy: 2 year follow up study.
    Subramaniam P; Konde S; Mathew S; Sugnani S
    J Clin Pediatr Dent; 2009; 33(4):311-4. PubMed ID: 19725237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and radiographic comparison of various medicaments used for pulpotomy in primary molars: A randomized clinical trial.
    Goyal P; Pandit IK; Gugnani N; Gupta M; Goel R; Gambhir RS
    Eur J Dent; 2016; 10(3):315-320. PubMed ID: 27403046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up.
    Ansari G; Ranjpour M
    Int Endod J; 2010 May; 43(5):413-8. PubMed ID: 20518934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study.
    Jayam C; Mitra M; Mishra J; Bhattacharya B; Jana B
    J Indian Soc Pedod Prev Dent; 2014; 32(1):13-8. PubMed ID: 24531596
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Kiranmayi T; Vemagiri CT; Rayala C; Chandrappa V; Bathula H; Challagulla A
    Dent Res J (Isfahan); 2022; 19():84. PubMed ID: 36426282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An 18 month evaluation of MM-MTA pulpotomy on primary decayed molars].
    Abou Chedid JC; Mchayleh N; Khalil I; Melki B; Hardan LS
    Odontostomatol Trop; 2015 Dec; 38(152):17-24. PubMed ID: 26939217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Success rate of three capping materials used in pulpotomy of primary molars: A randomized clinical trial.
    Abd Al Gawad RY; Hanafy RMH
    Saudi Dent J; 2021 Nov; 33(7):560-567. PubMed ID: 34803301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To Evaluate and Compare the Clinical and Radiographic Outcomes of Formocresol, Mineral Trioxide Aggregate, Electrocautery, and Bioactive Glass when used for Pulpotomy in Human Primary Teeth.
    Haideri S; Koul M; Raj R; Salam SA; Kalim MS; Gupta V
    J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1251-S1258. PubMed ID: 35017965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Outcomes of Pulpotomy with Propolis in Comparison with MTA in Human Primary Molars: A 24-month Follow-up Randomized Controlled Trial.
    RojaRamya KS; Chandrasekhar R; Uloopi KS; Vinay C
    Int J Clin Pediatr Dent; 2022; 15(Suppl 1):S3-S7. PubMed ID: 35645503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Radiographic Evaluation of Four Different Pulpotomy Agents in Primary Molars: A Longitudinal Study.
    Sunitha B; Puppala R; Kethineni B; K Mallela M; Peddi R; Tarasingh P
    Int J Clin Pediatr Dent; 2017; 10(3):240-244. PubMed ID: 29104382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineral Trioxide Aggregate Partial Pulpotomy Versus Formocresol Pulpotomy: A Randomized, Split-Mouth, Controlled Clinical Trial with 24 Months Follow-Up.
    Nematollahi H; Noorollahian H; Bagherian A; Yarbakht M; Nematollahi S
    Pediatr Dent; 2018 May; 40(3):184-189. PubMed ID: 29793564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized Controlled Trial of Pulpotomy in Primary Molars using MTA and Formocresol Compared to 3Mixtatin: A Novel Biomaterial.
    Jamali Z; Alavi V; Najafpour E; Aminabadi NA; Shirazi S
    J Clin Pediatr Dent; 2018; 42(5):361-366. PubMed ID: 29763354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative evaluation of four regenerative materials for pulpotomy in primary molars: An
    Manohar S; Bazaz N; Neeraja G; Subramaniam P; Sneharaj N
    Dent Res J (Isfahan); 2022; 19():102. PubMed ID: 36618772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.